Nefrosten Evalar, 0,25 g, tab. №60
- Active ingredient
- Золототысячника трава, Любистока лекарственного корни, Розмарина лекарственного листья
- Manufacturer
- Эвалар, ЗАО
Available in 69 pharmacies
from 102,000 soʻm
Minimum price
from 102,000 soʻm
Nefrosten Evalar instructions for use
Method of administration and dosage
Tablets should be taken orally, without chewing, with water.
Adults: 2 tablets 3 times a day. Children from 6 years old: 1 tablet 3 times a day. After the acute phase of the disease subsides, treatment with the preparation should be continued for 2-4 weeks.
During treatment with the preparation, it is recommended to consume a large amount of liquid.
If no improvement occurs during therapy or symptoms worsen, or new symptoms appear, it is necessary to consult a doctor.
Use the preparation only according to the indications, method of administration, and doses specified in the instructions.
Side effects
Allergic reactions are possible.
Gastrointestinal disorders (nausea, vomiting, diarrhea) are possible.
At the first signs of an allergic reaction, stop taking the preparation and consult a doctor.
If you experience side effects specified in the instructions, or they worsen, or you notice any other side effects not specified in the instructions, inform your doctor.
Overdose
To date, no cases of overdose have been reported. In case of overdose, symptomatic treatment is prescribed.
Interaction with other medicinal products
Combination with antibacterial agents is possible and advisable. There is no information on clinically significant interaction with other medicinal products.
In case of simultaneous use of any other medicinal products, consult a doctor.
Special instructions
In case of edema caused by heart or kidney dysfunction, consumption of a large amount of liquid is contraindicated.
In case of impaired kidney function, the preparation should not be prescribed as monotherapy. In case of inflammatory kidney disease, it is necessary to consult a doctor.
In case of blood in the urine, pain during urination, or acute urinary retention, it is necessary to consult a doctor immediately.
Influence on the ability to drive vehicles and operate machinery
The use of the preparation does not affect the ability to perform potentially dangerous activities that require increased concentration and speed of psychomotor reactions (including driving vehicles, working with moving machinery, dispatcher and operator work, etc.).
Form of release
Film-coated tablets.
20 tablets in a blister pack made of polyvinyl chloride film and flexible packaging based on aluminum foil.
1, 2, 3, 4, 5, 6 blister packs together with the instructions for use are placed in a cardboard box.
Storage conditions
At a temperature not exceeding 25 °C.
Keep out of reach of children.